Option Care Health (NASDAQ:OPCH) Releases FY 2025 Earnings Guidance

Option Care Health (NASDAQ:OPCH) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share guidance of 1.590-1.690 for the period, compared to the consensus earnings per share estimate of 1.240. The company issued revenue guidance of $5.2 billion-$5.4 billion, compared to the consensus revenue estimate of $5.2 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. Truist Financial dropped their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. JMP Securities reissued a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday. UBS Group initiated coverage on Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective on the stock. Finally, Barrington Research decreased their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $29.14.

Option Care Health Stock Up 11.7 %

Shares of OPCH opened at $26.80 on Monday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health has a 12-month low of $21.39 and a 12-month high of $34.63. The business’s 50 day moving average is $23.10 and its 200 day moving average is $27.69. The company has a market capitalization of $4.56 billion, a PE ratio of 22.52, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.64% of the stock is owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.